Clinical Research, Pharma & Healthcare FinancingAviadoBio Launches ASPIRE-FTD Phase 1/2 Trial in the UKBusiness WireMay 15, 2025August 1, 2025 by Business WireMay 15, 2025August 1, 20250111 – AVB-101 is an investigational one-time therapy designed to deliver a functional copy of the GRN gene directly to the brain, thereby potentially restoring progranulin levels...
